US Patent Issued to HANMI PHARM. on Oct. 20 for "Pharmaceutical composition comprising glucagon/GLP-1/GIP triple agonist or long-acting conjugate thereof for preventing or treating vasculitis" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,196, issued on Oct. 20, was assigned to HANMI PHARM. Co. LTD. (Hwaseong-si, South Korea).

"Pharmaceutical composition comprising glucagon/GLP-1/GIP triple agonist or long-acting conjugate thereof for preventing or treating vasculitis" was invented by Eun Jung Kim (Hwaseong-si, South Korea), Jae Hyuk Choi (Hwaseong-si, South Korea), Jung Kuk Kim (Hwaseong-si, South Korea), Won Ki Kim (Hwaseong-si, South Korea) and Euh Lim Oh (Hwaseong-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a pharmaceutical composition for preventing or treating vasculitis, including a glucagon/GLP-1/GIP triple agonist, a pharmaceutically acceptable...